Stoke Therapeutics, Inc. (STOK) Operating income 2018–2025
Stoke Therapeutics, Inc. (STOK) annual operating income history from SEC filings — each fiscal year as reported.
-$20.6MFY2025 · since FY2018: -$12.8M → -$20.6M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$20.6M | +79.7% |
| FY2024 | -$101.4M | +11.7% |
| FY2023 | -$114.8M | -10.0% |
| FY2022 | -$104.4M | -21.3% |
| FY2021 | -$86.1M | -62.3% |
| FY2020 | -$53.0M | -48.7% |
| FY2019 | -$35.7M | -179.1% |
| FY2018 | -$12.8M | — |
Source: SEC XBRL filings · For reference only · Not investment advice